Skye Bio amends 8-K to set Aug. 24 effective date for reverse stock split
SKYE•Reverse split effective date disclosed
Skye Bioscience filed an 8-K/A to correct its prior 8-K by disclosing the effective date of its reverse stock split.
The reverse split takes effect at 12:01 a.m. New York time on Aug. 24, 2026; Nasdaq trading switches to a split-adjusted basis at market open.
The common stock keeps the SKYE ticker; the post-split CUSIP changes to 83086J309.
